Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Percorten-V. Injectable 25 mg Suspension is a Health Canada–registered veterinary drug (DIN 02139227) held by Elanco Canada Limited, containing Desoxycortone Pivalate. Health Canada lists its status as Marketed (status date 16 Jan 2018). Nexara Health has matched 2 registrations of Desoxycortone Pivalate across 2 other regulated markets.

Health Canada registration

DIN02139227
Brand namePercorten-V. Injectable
Active ingredientDesoxycortone Pivalate
Strength25 mg
Dosage formSuspension
RouteIntramuscular
CompanyElanco Canada Limited
StatusMarketed — 16 Jan 2018
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Desoxycortone Pivalate registered in other markets

2 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
European Union (EMA)Zycortal—AuthorisedEMA centrally authorised
PolandZycortalDechra Regulatory B.V.25 mg/mlZawiesina do wstrzykiwań o przedłużonym uwalnianiuURPL RPL

See every manufacturer of Desoxycortone Pivalate worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Percorten-V. Injectable (DIN 02139227) marketed in Canada?

Yes. Health Canada lists DIN 02139227 as Marketed as of 16 Jan 2018.

Who holds the Canadian licence for this product?

Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.

Is Desoxycortone Pivalate registered outside Canada?

Yes — Nexara Health has matched 2 registrations in 2 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02139227, status date 2018-01-16; national medicine registries: EMA centrally authorised, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02139227, status date 2018-01-16; national medicine registries: EMA centrally authorised, URPL RPL.

Health Canada Drug Product Database (DPD), DIN 02139227, status date 2018-01-16; national medicine registries: EMA centrally authorised, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.